CMG
66
-4
STZ
52
-6
PCAR
56
-5
WBA
43
-4
SLG
57
-3
USB
50
-3
OI
42
-3
ZTS
47
2
ORCL
63
-4
HUM
41
-4
SIG
44
-3
AZO
50
-5
DTE
43
5
ROST
57
-3
NVDA
52
-5
CRM
60
-7
HSIC
45
5
NAVI
52
-2
DHI
44
-3
SCHW
62
-2
CMG
66
-4
STZ
52
-6
PCAR
56
-5
WBA
43
-4
SLG
57
-3
USB
50
-3
OI
42
-3
ZTS
47
2
ORCL
63
-4
HUM
41
-4
SIG
44
-3
AZO
50
-5
DTE
43
5
ROST
57
-3
NVDA
52
-5
CRM
60
-7
HSIC
45
5
NAVI
52
-2
DHI
44
-3
SCHW
62
-2
Financhill
Back

Counterpoint High Yield Trend ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
67

HYTR
Counterpoint High Yield Trend ETF

Last Price:
22.12
Seasonality Move:
0.71%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
67
Counterpoint High Yield Trend ETF (HYTR) is a Buy

Is Counterpoint High Yield Trend ETF a Buy, Sell or Hold?

  • The current Counterpoint High Yield Trend ETF [HYTR] share price is $21.85. The Score for HYTR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • HYTR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HYTR Stock Price Chart

What is Counterpoint High Yield Trend ETF's stock price today?

  • The Counterpoint High Yield Trend ETF share price today is $21.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HYTR is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

HYTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 39.58 Sell
Chaikin Money Flow: 1669 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.88 - 22.06) Sell
Bollinger Bands (100): (21.64 - 22.12) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

HYTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.02 Sell
20-day SMA: 21.95 Sell
50-day SMA: 22.04 Sell
200-day SMA: 21.63 Buy
8-day EMA: 21.97 Sell
20-day EMA: 21.98 Sell
50-day EMA: 21.97 Sell
200-day EMA: 21.68 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Counterpoint High Yield Trend ETF Earnings Growth & HYTR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Counterpoint High Yield Trend ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):